User Tools

Site Tools


pk_metabolism

Metabolism of drugs

Introduction

  • Generally, the metabolism of a drug decreases its lipid solubility by making it more polar and thus more hydrophilic, thereby facilitating excretion;

Phase I reaction:

  • Occur when there is a change in the drug molecule such as oxidation, reduction, or hydrolysis;

Oxidative:

  • 2 main types:
    • 1. microsomal (mainly liver):
      • i) oxgenation (O, OH, NOH, NO, SO);
      • ii) oxygenation with cleavage;
    • 2. other:
      • i) mitochondrial: monoamine oxidase;
      • ii) transmitter vesicle hydroxylases;
      • iii) cytoplasmic:
        • alcohol/aldehyde dehydrogenases;
        • xanthine oxidase → uric acid;
        • tyrosine/tryptophan hydroxylases;
      • iv) plasma:
        • diamine oxidases (eg. histaminase);
      • v) metallic (ferrous→ferric;arsenic);
      • vi) sulphides → sulphates;
      • vii) sulphydryls → sulphuric acid esters/sulphonic;

Reductions:

  • Less common than oxidative (mainly microsomal);
  • i) azo & nitro groups to amines;
  • ii) dehalogenation (eg. halothane minor route only);
  • iii) aldehydes to 1o alcohols (chloral to trichloroethanol);
  • iv) ketones to 2o alcohols (oestrone to oestradiol);
  • v) pentavalent arsenic to trivalent;
  • vi) disulphides to sulphydryl derivatives;
    • (eg. disulfiram to diethyldithiocarbamic acid);

Hydrolytic:

  • i) alcohol esterases (blood, liver, kidney, etc):
    • cholinesterase;
    • atropine; cocaine; procaine; pethidine;
  • ii) amide esterases (hydrolysed more slowly than alcohol ones):
    • procainamide; phenytoin (minor route);
  • iii) hydrazides:
    • iproniazid;
  • iv) glycosides - removal of glycose residues from glycosides alters their lipid/aqueous distribution & their ph/dynamic activity;

Phase II reaction:

  • Occur when drug is conjugated;
  • i) glucuronide conjugates in hepatocytes:
    • paracetamol; morphine; steroids; salicylic acid; indocid;
    • sulphonamides; dapsone;
  • ii) sulphate conjugates (sulphokinase in intest.,liver, kidney)
    • phenols (mainly intestinal mucosa or kidney(if from ph.I)
    • catechols (eg. isoprenaline) (mainly intsetinal mucosa);
    • sterols (mainly liver);
  • iii) acetyl conjugates:
    • hepatic: (genetic) isoniazid, hydrallazine;
    • elsewhere: sulphanilamide; p-amino benzoic acid;
  • iv) amino acid conjugates:
    • glycine: salicylic acid derivs.; nicotinic acid;
  • v) methyl conjugates:
    • sympathomimetic amines; histamine; serotonin; nicotine;

Prodrugs:

  • prontosil → sulphanilamide;
  • chloral hydrate → trichloroethanol;
  • L-dopa → dopamine;
  • methyldopa → alpha methyl noradrenaline;
  • cortisone → hydrocortisone;
  • prednisone → prednisolone;
  • glyceryl triacetate → acetic acid;

Toxic metabolites:

  • halothane → trifluoroacetic acid;
  • sulphonamides → acetylated sulphonamide conjugate → crystals;
  • methanol → formaldehyde → retinopathy;

Examples of drug inhibition of microsomal enzymes & the drug metabolised:

  • acute ethanol → phenobarbitone; phenytoin; tolbutamide; warfarin;
  • chloral hydrate → ethanol;
  • disulfiram → ethanol; phenytoin; warfarin;
  • warfarin → phenytoin;

====Examples of drug induction of microsomal enzymes & the drug metabolised:

  • chronic ethanol ⇒ ethanol; isoniazid; phenobarbitone; phenytoin; tolbutamide; warfarin;
  • carbamazepine ⇒ phenytoin; warfarin;
  • griseofulvin ⇒ warfarin;
  • phenobarbitone
    • ⇒ethanol; chlorpromazine; codeine; digitoxin; oestradiol; pethidine;
    • ⇒phenobarbitone; phenytoin; quinine; testosterone; thyroxine; warfarin;
  • phenytoin ⇒ digitoxin; phenobarbitone; thyroxine;
  • rifampicin ⇒ oestrogens, warfarin; dicoumarol;

Pharmacogenetics:

  • Most genetic variations in drug metabolism are multifactorial & have a Gaussian population distribution, but some enzyme activities have been identified as having discontinuity, thus two or more populations:
    • fast/slow acetylators: isoniazid/hydrallazine/some sulpha's;
    • phenytoin microsomal metabolism;
    • plasma pseudocholinesterase:
      • suxamethonium (autosomal codominant - 4 separate genes at 1 locus);
    • Acatalasia: tissue catalase activity <1% normal;
    • G6PD defic.: sulphonamides; etc;
    • Hb defects: sulphonamides may cause metHb in heterozygotes;
    • porphyrias: ethanol/sulpha's/osetrogens/tranquillisers/etc;
    • warfarin resistance;
    • steroid induced glaucoma;
    • mydriatics work much better in blue eyes than dark eyes!
    • malignant pyrexia;
pk_metabolism.txt · Last modified: 2009/04/09 02:32 by 127.0.0.1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki